Mogens Vang Rasmussen
Corporate Officer/Principal at Vesicon SAS
Network origin in Mogens Vang Rasmussen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 24 | |
Vesicon SAS
 Vesicon SAS Medical SpecialtiesHealth Technology Vesicon SAS is a French company that manufactures ultrasonic therapy devices. The company is based in Meylan, France. The company was founded in 2015.
1
| Holding Company | Medical Specialties | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mogens Vang Rasmussen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Masters Business Admin | |
| ATON | Pharmaceuticals: Major | Chairman Chairman | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| MITHRA PHARMACEUTICALS S.A. | Pharmaceuticals: Major | Chief Executive Officer | |
| Copenhagen Business School | College/University | Undergraduate Degree Graduate Degree | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Aarhus | College/University | Corporate Officer/Principal Graduate Degree | |
Zymenex A/S
 Zymenex A/S BiotechnologyHealth Technology Zymenex A/S researches and develops therapeutics for life threatening diseases. The firm commercializes novel enzyme replacement therapies for the treatment of life-threatening, rare genetic diseases. The company was founded by Jens Fogh and Pär Gellerfors in 1998 and is headquartered in Hillerod, Denmark. | Biotechnology | Chairman Chairman | |
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chairman Director/Board Member Chairman | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Lund | College/University | Graduate Degree Doctorate Degree | |
| University of Copenhagen | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Corporate Officer/Principal | |
| International Institute for Management Development | College/University | Undergraduate Degree Masters Business Admin | |
| University of Southern Denmark | College/University | Masters Business Admin | |
| Danmarks Farmaceutiske Universitet | College/University | Graduate Degree Graduate Degree | |
7TM A/S
 7TM A/S Pharmaceuticals: MajorHealth Technology 7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark. | Pharmaceuticals: Major | Founder | |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Warren Pharmaceuticals, Inc.
 Warren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Warren Pharmaceuticals, Inc. develops tissue-protective technologies. The company was founded by Anthony Cerami and Michael Brines on May 17, 2001 and is headquartered in Tarrytown, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member Director/Board Member | |
| ADOCIA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PHARNEXT SCA | Biotechnology | Chief Executive Officer | |
AM-Pharma BV
 AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
| Centre Hospitalier Universitaire de Montpellier | College/University | Corporate Officer/Principal | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Medesis SA | Director/Board Member | ||
Bankinvest Biomedical Venture
 Bankinvest Biomedical Venture Investment ManagersFinance Bankinvest Biomedical Venture provides investment services. The company was founded in 1998 and is headquartered in Copenhagen, Denmark. | Investment Managers | Corporate Officer/Principal | |
Key Neurosciences SAS
 Key Neurosciences SAS Miscellaneous Commercial ServicesCommercial Services Key Neurosciences SAS provides research and development services. Its services include product and technology development, fund raising, business and commercial development, and project management. The company was founded in December 2010 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| Columbia University College of Physicians & Surgeons | College/University | Corporate Officer/Principal | |
Alpha Healthcare Investments ApS
 Alpha Healthcare Investments ApS Miscellaneous Commercial ServicesCommercial Services Alpha Healthcare Investments ApS provides business and management consulting services. The private company is based in Virum, Denmark. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Lakeside Invest ApS
 Lakeside Invest ApS Financial ConglomeratesFinance Lakeside Invest ApS provides financial services. | Financial Conglomerates | Corporate Officer/Principal | |
| Obton Solenergi Sinope Komplementaranpartsselskab | Corporate Officer/Principal | ||
| Copenhagen Innovation Capital Management ApS | Corporate Officer/Principal | ||
Silence Therapeutics GmbH
 Silence Therapeutics GmbH BiotechnologyHealth Technology Part of Silence Therapeutics Plc, Silence Therapeutics GmbH is a German biotechnology company that develops RNAi-based drugs. The company is based in Berlin, Germany and was founded in 2014. | Biotechnology | Chief Executive Officer | |
Ixaka Ltd.
 Ixaka Ltd. BiotechnologyHealth Technology Ixaka Ltd. engages in the development of advanced cell-based therapeutics for the treatment of critical limb ischemia. The company was founded by Gaby Salem and Vicente Saez Gonzalez in 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman | |
| AMNIOTICS AB | Biotechnology | Corporate Officer/Principal | |
Pharmacosmos A/S
 Pharmacosmos A/S Pharmaceuticals: MajorHealth Technology Pharmacosmos A/S develops treatments of iron deficiency anemia in humans and animals. Its products include monofer, cosmofer, diafer and uniferon. The company was founded by Dr. Henry M. Christensen in 1965 and is headquartered in Holbæk, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistics
International
| Denmark | 23 |
| France | 11 |
| Switzerland | 4 |
| United States | 4 |
| Sweden | 4 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 12 |
| Finance | 6 |
| Commercial Services | 5 |
Operational
| Director/Board Member | 183 |
| Corporate Officer/Principal | 57 |
| Chairman | 48 |
| Chief Executive Officer | 28 |
| Independent Dir/Board Member | 26 |
Most connected contacts
| Insiders | |
|---|---|
| Peter James Arthur Benson | 58 |
| Alain Munoz | 38 |
| Christian Herskind Jørgensen | 35 |
| Rémi Droller | 29 |
| Michael Gustav Brock | 22 |
| David Solomon | 22 |
| Jean-Christophe Renondin | 15 |
| Florian Reinaud | 15 |
| Bo Lennart Bruce | 15 |
| Jesper Zeuthen | 13 |
| Anders Fink Vadsholt | 13 |
| Daniël Jan Ellens | 13 |
| Thomas Tscherning | 13 |
| Jürgen Langhärig | 11 |
| Jens W. Kindtler | 9 |
- Stock Market
- Insiders
- Mogens Vang Rasmussen
- Company connections
